• Gioel Gabrio Secco, Chiara Zocchi, Rosario Parisi, Annalisa Roveta, Francesca Mirabella, Matteo Vercellino, Gianfranco Pistis, Maurizio Reale, Silvia Maggio, Andrea Audo, Daniela Kozel, Giacomo Centini, Antonio Maconi, and Carlo Di Mario.
• Department of Cardiology, Interventional Cardiology and Cardiac Surgery, Azienda Ospedaliera SS, Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Department of Cardiology, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. Electronic address: gioel.gabrio.secco@gmail.com.
• Can J Cardiol. 2020 Jul 1; 36 (7): 1152-1155.

AbstractThe diffusion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) forced the Italian population to restrictive measures that modified patients' responses to non-SARS-CoV-2 medical conditions. We evaluated all patients with acute coronary syndromes admitted in 3 high-volume hospitals during the first month of SARS-CoV-2 Italian-outbreak and compared them with patients with ACS admitted during the same period 1 year before. Hospitalization for ACS decreased from 162 patients in 2019 to 84 patients in 2020. In 2020, both door-to-balloon and symptoms-to-percutaneous coronary intervention were longer, and admission levels of high-sensitive cardiac troponin I were higher. They had a lower discharged residual left-ventricular function and an increased predicted late cardiovascular mortality based on their Global Registry of Acute Coronary Events (GRACE) scores.Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

40 keywords...

hide…